Tech & Reports

Liver disease is accelerating into a global health priority, driven by rising rates of metabolic disorders and the silent progression of early-stage liver injury. While conditions such as steatosis may be reversible, unchecked progression can lead to fibrosis, cirrhosis, and hepatocellular carcinoma—diseases that carry significant clinical and economic burden. Today, more than one in four adults worldwide are affected by NAFLD, and over 900,000 new liver cancer cases are reported each year, highlighting the urgent need for earlier, more accessible, and more standardized evaluation.

VINNO’s MPUS Liver Solution responds to this challenge with a modern, data-driven approach to liver assessment. By integrating advanced multimodal ultrasound imaging with AI-enabled quantification, MPUS delivers a comprehensive, non-invasive framework that supports accurate detection, staging, and longitudinal monitoring. The platform transforms routine ultrasound into a powerful clinical tool—providing clear visualization, reproducible metrics, and deeper diagnostic insight to guide confident decision-making across the full spectrum of liver disease.

Why Liver Assessment Needs a New Approach

Traditional liver disease evaluation methods often lack sensitivity in early stages and can be invasive or inconsistent. As NAFLD and metabolic liver disorders become increasingly prevalent, clinicians require diagnostic tools that:

• Deliver quantitative and reproducible data

• Detect subtle parenchymal changes earlier

• Visualize microvascular and perfusion dynamics

• Fit seamlessly into routine ultrasound workflows

MPUS was developed to meet these evolving clinical expectations

What the MPUS Liver Solution Offers

The MPUS Liver Solution integrates several advanced ultrasound technologies into a unified diagnostic framework:

• Steatosis assessment through tissue attenuation and automated HRI

• Fibrosis staging using shear-wave stiffness measurement (VShear / p-VShear)

• Microvascular evaluation enabled by SMF and CEUS

• Ultra-resolution microscopy (URM) imaging for early lesion visibility

• AI-assisted quantification for standardization and consistency

Together, these tools support evidence-based assessment across the full continuum of liver disease

Making Routine Ultrasound More Powerful

By combining multimodal imaging and quantitative analysis, MPUS elevates routine ultrasound from a qualitative screening tool to a structured clinical decision-support platform—enhancing diagnostic accuracy, enabling consistent follow-up, and improving patient management outcomes.